Monitoring the Saphir Stem in Hip Surgery
Official title: Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery
Run by Gruppo Bioimpianti S.r.l. · NCT05649007 · Data updated 2026-11-12
This study looks at how well the Saphir stem used in hip replacement surgery works for patients over time, focusing on their recovery and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 630 (estimated) |
| Sponsor | Gruppo Bioimpianti S.r.l. Industry-sponsored |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | September 30, 2022 |
| Main results expected | September 30, 2035 |
| Study ends | September 30, 2036 |
| Registry record updated | December 13, 2022 |
| Trial ID | NCT05649007 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old who are scheduled for primary total hip replacement due to osteoarthritis or femoral neck fractures.
✕Probably not a fit
Patients under 18, those who are pregnant, or individuals with prior hip surgery on the same side will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the long-term survival rate of the Saphir stem used in primary hip arthroplasty. It involves post-marketing surveillance to assess patient outcomes, including functional improvement, quality of life, and safety related to the prosthesis. Patients undergoing hip replacement surgery with the Saphir stem and associated systems will be monitored for adverse events and overall effectiveness over time.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the durability and effectiveness of the Saphir stem, potentially improving patient outcomes in hip arthroplasty.
How similar studies have gone: While this study focuses on post-marketing surveillance, similar studies have shown success in evaluating the long-term outcomes of hip prostheses.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients\>18 years * Candidate for primary total hip replacement with femoral stem and acetabular cup * if ostheoarthritis patients aged 18 to 85 years * if femoral neck fracture patients aged 18 to 90 years * patients with social security scheme * patients understands the condition of the study and is willing to partecipate for the duration of the clinical investigation * patients who gavee consent to partecipare in the clinical investigation Exclusion Criteria: * \<18 years * if female, pregnant * patient who has already had primary hip surgery on the same side * local or disseminated neoplastic disease * inability to understand the study and agree to partecipate * patients cancelling partecipation before surgery * patients under guardianship or curatorship * patients without a social security scheme * patients refusing to partecipate
Where it's running
-
Hopital Ducuing
Toulouse, France Recruiting
Study contacts
- Principal investigator: Gerard Giordano, medicine — Hopital Ducuing
- Study coordinator: Alessio Vitale, Biotech
- Email: regulatory@bioimpianti.it
- Phone: +390251650371
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mako-MORE Registry: Real-world Outcomes After Knee and Hip Arthroplasty
This registry collects real-world data from adults having hip or knee joint replacement with or without the Mako robotic system to see how they do over up to five years.
-
Spinal anesthesia with intrathecal morphine vs PENG block (with or without dexamethasone) for hip replacement
In people aged 60 and older undergoing total hip arthroplasty, this study tests whether three anesthesia approaches provide better pain control and fewer side effects: spinal with intrathecal morphine, spinal with a PENG block, or spinal with a PENG block plus dexamethasone.
-
PENG Block or Periarticular Injection for Hip Surgery in Older Adults
This study tests three pain-relief approaches after hip surgery in adults 65 and older to see which best eases pain while keeping movement safe.
-
PENG nerve block plus dexmedetomidine for hip surgery pain in older adults
This will test whether adding a small dose of dexmedetomidine to a PENG nerve block gives longer, better pain relief and reduces opioid need for people 65 and older having hip surgery.
-
Comparing two nerve-block approaches for pain after anterior-approach hip replacement
This trial tests whether adding a lateral femoral cutaneous nerve block or using surgical wound infiltration together with a PENG block gives better pain relief after anterior-approach total hip replacement.
-
Breathing exercises before joint surgery
This study is testing if breathing exercises before joint surgery can help patients breathe better after their operation and avoid complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.